% decrease. The promising growth of non-SW revenue was from IPD (49% growth) followed by OPD (14% growth) yoy. Both number of patients and revenue per head of 4Q19 increased. The higher revenue per head
declined yoy whereas revenue per head remained on the rise. The increase of revenue per head was Operation : Consolidated Profit & Loss Statement 3Q 3Q % 9 mth 9 mth % Unit : THB million 2019 2018 change
(with more than 50% control) Controlling structure in reverse takeovers 4 Merged firm Combined value $12.6 mn (63 mn shares x $0.2 Private firm value $ 10 mn (50 mn shares x $0.2) Public firm
Indorama Ventures Public Company Limited for the year ended December 31, 2019 We are pleased to submit: 1. Consolidated and Company only Annual Audited Financial Statements for the year ended December 31
MATI 19/2560 November 13, 2017 Subject Consolidated Financial Report for the nine-month period which ended at September 30, 2017 To Director and Manager The Stock Exchange of Thailand Nine-month
”) would like to explain major factors that affect Y2019 consolidated operating results as follows: ▪ MDX has only THB 27.36 million of land-sale revenue in 2019 from about 8 rai of land title deed transfer
MATI 07/2561 February 27, 2018 Subject Consolidated Financial Report for the year which ended at December 31, 2017 To Director and Manager The Stock Exchange of Thailand Operating income of Matichon
% of total assets of the Company as compared to the consolidated financial statement for the period ended September 30, 2018. When combined with transactions occurring in the past 6 months, the
assets method according to the consolidated financial statements of the Company as of September 30, 2018 and when combined with the acquisition of assets in the period of 6 months occurred before the date
3.15 (2)% 3% Consolidated Revenue1 2,343 2,942 2,930 (20)% (20)% Core EBITDA2,3 305 304 361 0% (16)% Combined PET 225 192 284 17% (21)% Integrated Oxides and Derivatives 34 50 26 (32)% 33% Fibers 37 61